CannaPharmaRx, Inc. (CPMD)
0.0038
0.00 (0.00%)
USD |
OTCM |
May 18, 10:54
CannaPharmaRx Cash from Investing (Quarterly) : -0.0055M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -0.0539M |
| InMed Pharmaceuticals, Inc. | 0.00 |
| Target Group, Inc. (Canada) | -0.0401M |
| Tilray Brands, Inc. | 28.63M |
| NervGen Pharma Corp. | 0.0061M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.061M |
| Cash from Financing (Quarterly) | -1.055M |
| Free Cash Flow | -0.7891M |
| Free Cash Flow Per Share (Quarterly) | 0.0016 |
| Free Cash Flow to Equity (Quarterly) | 0.4305M |
| Free Cash Flow to Firm (Quarterly) | 1.544M |
| Free Cash Flow Yield | -31.49% |